Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ProgynyPGNY +1.60%94 Market Cap is $2,444 Mil as of Jul. 26, 2026. GuruFocus rates PGNY with a GF Score™ of 94/100 and a GF Value™ of $28.55 (Fairly Valued). The stock has 6 warning signs investors should review. Among 18 Healthcare Plans companies, Progyny ranks worse than 61.11% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Progyny's share price for the quarter that ended in Mar. 2026 was $16.98. Progyny's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 78 Mil. Therefore, Progyny's market cap for the quarter that ended in Mar. 2026 was $1,329 Mil.
Progyny's quarterly market cap
increased
from Sep. 2025 ($1,854 Mil) to Dec. 2025 ($2,141 Mil) but then
declined
from Dec. 2025 ($2,141 Mil) to Mar. 2026 ($1,329 Mil).
Progyny's annual market cap
declined
from Dec. 2023 ($3,582 Mil) to Dec. 2024 ($1,472 Mil) but then
increased
from Dec. 2024 ($1,472 Mil) to Dec. 2025 ($2,141 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Progyny's Enterprise Value for Today is $2,242 Mil.
Progyny (NAS:PGNY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Progyny Market Cap Related Terms
Progyny Market Cap Historical Data
* Premium members only.
The historical data trend for Progyny's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Progyny's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny Market Cap vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Progyny's Market Cap distribution charts can be found below:
* The bar in red indicates where Progyny's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Progyny's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progyny (PGNY) has a Market Cap of $2,444 Mil as of Jul. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Progyny and its competitors. According to the industry distribution chart, Progyny ranks #11 out of 18 companies in the Healthcare Plans industry, placing it in the top 61.1%.
Is Progyny's Market Cap too high?
Progyny's current Market Cap is $2,444 Mil. The Healthcare Plans industry median Market Cap is 6,215.19. Progyny's value of $2,444 Mil is 60.7% below this industry median. Based on the distribution chart, Progyny ranks #11 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Progyny has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Progyny's Market Cap compare to CLOV and PFHO?
According to the Healthcare Plans industry distribution chart, Progyny ranks #11 out of 18 companies for Market Cap. This places Progyny in the lower half of its industry. The industry median Market Cap is 6,215.19. Progyny's value of $2,444 Mil is 60.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Plans company?
The median Market Cap among Healthcare Plans companies is 6,215.19, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Progyny's current Market Cap of $2,444 Mil is 60.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Progyny and its competitors. For the Healthcare Plans industry, the median Market Cap is 6,215.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current Market Cap is $2,444 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Fairly Valued. The stock's GF Value™ is $28.55, compared to a current price of $31.20 — trading 9.3% above its estimated fair value. The current Market Cap is $2,444 Mil and 60.7% below the Healthcare Plans industry median of 6,215.19. Progyny's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Progyny (PGNY), the current Market Cap is $2,444 Mil as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Progyny (PGNY) Overvalued in 2026?
Based on GuruFocus' analysis, Progyny stock appears to be overvalued.
The current stock price of $31.20 is trading 9.3% above its estimated GF Value™ of $28.55.
GuruFocus considers Progyny to be Fairly Valued.
Key valuation signals for PGNY:
Market Cap: $2,444 Mil
GF Value™: $28.55 vs. price of $31.20 (9.3% above fair value)
Industry Position: 60.7% below the Healthcare Plans median (#11 of 18)
No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
94GF Score
Get the complete analysis for PGNY
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PGNY has been successfully added to your 
